Texas Hospital Administers Cerner's (CERN) Millenium System

Cerner Corporation 's CERN coveted electronic health record (EHR) system - Cerner Millennium - has been recently administered by Texas-based Rankin County Hospital District ("RCHD"). The platform will ensure improved patient experience.

Notably, RCHD is a health and wellness body, which serves the West Texas community. The Cerner Millennium EHR offers sophisticated health care technology to help doctors and nurses streamline their operations for better results.

RCHD will deploy the new EHR through the Cerner CommunityWorks model. Notably, the model uses cloud technology to deliver the power of Cerner Millennium. It is customized to support the unique needs of community, critical access and specialty hospitals. RCHD staffs can now access a digital record of their patients' health history, including real-time clinical and financial data.

Cerner Corporation Price and Consensus

Cerner Corporation Price and Consensus | Cerner Corporation Quote

Cerner's EHR is providing comprehensive care to RCHD's 15-bed critical access hospital. Resultantly, this has impacted RCHD's daily revenue cycle meetings, allowing management to handle operations.

Additionally, the platform will ensure improved patient engagement through its new online portal for communication between patients and the hospital.

Latest Developments in Cerner's EHR Front

Cerner's EHR, comprising electronic patient record (EPR) or electronic medical record (EMR), is the basis of all core clinical solutions. Lately, the EHR platform has witnessed a glut of developments.

Cerner Millennium and Cerner HealtheIntent were recently implemented at California-based Kern Medical, a 222-bed acute care teaching center.

Cerner HealtheIntent was recently picked by Illinois Rural Community Care Organization, across its units to coordinate care for Medicare patients throughout the state.

In February, Cerner Millennium was selected by University of Missouri Health Care, Columbia, to help manage revenue cycle performance across its five hospitals and more than 50 primary and specialty care clinics.

Price Performance

We believe, these developments are going to provide a cushion to Cerner's stock that has declined 5.1% in a year's time, against the industry 's gain of 3.7%.

Cerner carries a Zacks Rank #3 (Hold).

Zacks Rank & Key Picks

A few better-ranked stocks in the broader medical space are, BIOHAVEN PHARM BHVN , Bio-Rad Laboratories, Inc. BIO and Envision Healthcare Corporation EVHC . While BIOHAVEN and Bio-Rad sport a Zacks Rank #1 (Strong Buy), Envision carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank stocks here.

BIOHAVEN has an expected growth rate of 50% for the current quarter and a growth rate of 42.1% for the next quarter.

Bio-Rad has an expected long-term growth rate of 20% and that for the current year is 42.9%.

Centene has an expected long-term growth rate of 13% and that for the next quarter is 10.6%.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Cerner Corporation (CERN): Free Stock Analysis Report

Bio-Rad Laboratories, Inc. (BIO): Free Stock Analysis Report

Envision Healthcare Corporation (EVHC): Free Stock Analysis Report

BIOHAVEN PHARM (BHVN): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics


Latest Markets Videos